Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Tarsus Pharmaceuticals, Inc.
TARS
Segment Reporting Other Item Amount
Segment Reporting Other Item Amount at other companies
Century Communities
CCS
$22.22M
+279%
Equitable Holdings
EQH
$371M
-5.1%
Essential Utilities
WTRG
-$75K
+74.4%
Proto Labs
PRLB
$128.08M
+5.2%
AvePoint, Inc.
AVPT
$14.34M
+6.5%
Whirlpool
WHR
$407M
-0.2%
Segments
By segment
See full
Reportable Segment
-$845K
-173%
Other financials
Income statement
See full
Revenue
$162.1M
+107%
Gross profit
$152.7M
+109%
Operating income
-$6.1M
+76.7%
Net income
-$7.0M
+72.3%
EPS (diluted)
-$0.16
+75.0%
Balance sheet
See full
Cash & equivalents
$104.2M
-41.6%
Total debt
$88.7M
+22.5%
Total equity
$349.0M
+1.9%
Total assets
$581.1M
+16.1%
Cash flow
See full
Operating cash flow
-$24.7M
-19.4%
CapEx
$5.8M
+886%
Free cash flow
-$30.5M
-43.4%
Valuation
See full
Market cap
$2.85B
+41.1%
Enterprise value
$2.83B
+47.8%
P/S
5.3×
-3.3×
Profitability
See full
Gross margin
42.7%
—
Operating margin
-9.5%
-4.2pp
Net margin
-9%
-4.0pp
FCF margin
-28%
-12.6pp
Returns & leverage
See full
Return on equity
-14%
-5.2pp
Debt / equity
0.3×
0.0×
Current ratio
3.7×
-1.8×
